BSX
BOSTON SCIENTIFIC CORPCompany Information
- Company Name
- BOSTON SCIENTIFIC CORP
- CIK
- CIK0000885725
- Category
- Large accelerated filer
- Ticker: Exchange
- BSX: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- BSX
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-20
- Last sale
- 2026-02-02
- Shares purchased (TTM)
- 7,600
- Shares sold (TTM)
- 697,861
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 1,256,844,528
- Shares outstanding
- 1,484,900,000
- Ownership
- 84.64%
Earnings Market Reaction
- Filing date
- 2026-08-03
- Price on filing date
- —
- 1-month reaction
- -3.28%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 539 | 1,453 | 1,965 | 1,275 | 534 | 725 | 414 | 2,502 | 2,913 | 2,329 | 865 | 952 | ||||||
| Accounts Notes And Loans Receivable Net Current | 3,049 | 3,027 | 2,926 | 2,828 | 2,815 | 2,693 | 2,558 | 2,501 | 2,400 | 2,304 | 2,228 | 2,101 | ||||||
| Inventory Net | 3,235 | 3,117 | 2,943 | 2,921 | 2,861 | 2,867 | 2,810 | 2,753 | 2,608 | 2,561 | 2,484 | 2,404 | ||||||
| Prepaid Taxes | 390 | 358 | 299 | 310 | 298 | 294 | 307 | 332 | 315 | 319 | 315 | 307 | ||||||
| Prepaid Expense And Other Assets Current | 760 | 729 | 660 | 701 | 613 | 756 | 831 | 674 | 756 | 671 | 621 | 741 | ||||||
| Assets Current | 7,972 | 8,684 | 8,794 | 8,035 | 7,121 | 7,335 | 6,920 | 8,761 | 8,991 | 8,185 | 6,514 | 6,504 | ||||||
| Other Long Term Investments | 2,245 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 4,126 | 4,063 | 4,036 | 3,795 | 3,461 | 3,389 | 3,294 | 3,072 | 2,951 | 2,897 | 2,859 | 2,635 | ||||||
| Goodwill | 18,640 | 18,536 | 18,282 | 18,214 | 18,076 | 17,340 | 17,089 | 15,033 | 14,397 | 14,361 | 14,387 | 13,608 | ||||||
| Intangible Assets Net Excluding Goodwill | 6,918 | 7,060 | 7,019 | 7,162 | 7,260 | 6,566 | 6,684 | 5,754 | 5,417 | 5,839 | 6,003 | 5,849 | ||||||
| Deferred Income Tax Assets Net | 3,909 | 3,953 | 3,675 | 3,669 | 3,778 | 3,676 | 3,655 | 3,816 | 3,801 | 3,792 | 3,841 | 3,840 | ||||||
| Other Assets Noncurrent | 1,405 | 2,054 | 1,866 | 1,832 | 1,864 | 1,834 | 1,754 | 1,642 | 1,551 | 1,596 | 1,531 | 1,605 | ||||||
| Assets | 45,216 | 44,351 | 43,673 | 42,707 | 41,559 | 40,140 | 39,395 | 38,078 | 37,108 | 36,669 | 35,136 | 34,043 | ||||||
Liabilities Current | ||||||||||||||||||
| Debt Current | 1,709 | 41 | 299 | 483 | 480 | 777 | 1,778 | 1,652 | 1,580 | 1,085 | 531 | 513 | ||||||
| Accounts Payable Current | 1,231 | 1,141 | 1,144 | 1,002 | 962 | 1,004 | 960 | 907 | 906 | 921 | 942 | 929 | ||||||
| Accrued Liabilities Current | 2,756 | 2,514 | 3,201 | 2,981 | 2,797 | 2,354 | 2,773 | 2,460 | 2,320 | 2,083 | 2,646 | 2,255 | ||||||
| Other Liabilities Current | 732 | 875 | 795 | 862 | 952 | 923 | 887 | 891 | 770 | 827 | 814 | 882 | ||||||
| Liabilities Current | 6,428 | 4,571 | 5,439 | 5,328 | 5,190 | 5,058 | 6,399 | 5,910 | 5,576 | 4,916 | 4,933 | 4,579 | ||||||
| Long Term Debt And Capital Lease Obligations | 10,915 | 10,988 | 11,137 | 11,117 | 11,107 | 10,532 | 8,968 | 9,233 | 8,991 | 9,534 | 8,571 | 8,386 | ||||||
| Deferred Income Tax Liabilities Net | 221 | 219 | 220 | 242 | 226 | 158 | 155 | 138 | 132 | 132 | 134 | 91 | ||||||
| Other Liabilities Noncurrent | 2,480 | 2,469 | 2,405 | 2,390 | 2,383 | 1,946 | 1,870 | 1,841 | 1,800 | 1,919 | 1,967 | 1,858 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | ||||||
| Treasury Stock Value | -4,318 | -2,251 | -2,251 | -2,251 | -2,251 | -2,251 | -2,251 | -2,251 | -2,251 | -2,251 | -2,251 | -2,251 | ||||||
| Additional Paid In Capital Common Stock | 21,717 | 21,584 | 21,505 | 21,419 | 21,230 | 21,127 | 21,056 | 20,963 | 20,803 | 20,713 | 20,647 | 20,573 | ||||||
| Retained Earnings Accumulated Deficit | 7,818 | 6,912 | 5,571 | 4,899 | 4,144 | 3,347 | 2,673 | 2,107 | 1,639 | 1,314 | 819 | 315 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -304 | -398 | -610 | -689 | -722 | -28 | 275 | -128 | 164 | 132 | 49 | 231 | ||||||
| Stockholders Equity | 24,930 | 25,864 | 24,472 | 23,630 | 22,418 | 22,212 | 21,770 | 20,956 | 20,371 | 20,168 | 19,282 | 18,886 | ||||||
| Minority Interest | 242 | 240 | 239 | 236 | 235 | 233 | 233 | 248 | 238 | 242 | 248 | 243 | ||||||
| Liabilities And Stockholders Equity | 45,216 | 44,351 | 43,673 | 42,707 | 41,559 | 40,140 | 39,395 | 38,078 | 37,108 | 36,669 | 35,136 | 34,043 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | - | 0.01 | 0.01 | 0.01 | - | 0.01 | 0.01 | 0.01 | - | 0.01 | ||||||
| Preferred Stock Shares Authorized | 50 | 50 | - | 50 | 50 | 50 | - | 50 | 50 | 50 | - | 50 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 | - | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | - | 0.01 | 0.01 | 0.01 | - | 0.01 | 0.01 | 0.01 | - | 0.01 | ||||||
| Common Stock Shares Authorized | 2,000 | 2,000 | - | 2,000 | 2,000 | 2,000 | - | 2,000 | 2,000 | 2,000 | - | 2,000 | ||||||
| Common Stock Shares Issued | 1,750 | - | - | 1,746 | 1,744 | 1,742 | - | - | 1,734 | - | - | 1,728 | ||||||
| Treasury Stock Common Shares | 303 | 263 | - | 263 | 263 | 263 | - | 263 | 263 | 263 | - | 263 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBOSTON SCIENTIFIC CORP (BSX) — SEC Financial Statements & Analysis
BOSTON SCIENTIFIC CORP (BSX) is a surgical & medical instruments & apparatus company, incorporated in DE. BOSTON SCIENTIFIC CORP trades on NYSE as: BSX. BOSTON SCIENTIFIC CORP (BSX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-03. Based on that filing, BOSTON SCIENTIFIC CORP carries a market cap of $62.75B, a P/E ratio of 17.11x, a P/B ratio of 2.52x, a P/S ratio of 2.99x, an enterprise value of $74.62B, and an EV/EBITDA multiple of 13.41x. On profitability, it posts a gross margin of 69.93%, an operating margin of 19.78%, a net margin of 17.47%, a Return on Equity (ROE) of 15.49%, a Return on Assets (ROA) of 8.45%, and a Return on Invested Capital (ROIC) of 11.10%. Per share, it reports EPS of $2.49, diluted EPS of $2.49, free cash flow per share of $2.47, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 13.52% year-over-year, net income growth of 46.15% year-over-year, and EPS growth of 47.12% year-over-year. On the balance sheet, it maintains a current ratio of 1.24x, a quick ratio of 0.62x, working capital of $1.54B, a debt-to-equity ratio of 0.26x, a debt ratio of 0.14, an interest coverage ratio of 11.44x, free cash flow of $3.63B (TTM), and net debt of $11.87B. Figures sourced from SEC EDGAR.
- Market Cap
- $62.75B
- P/E TTM
- 17.11x
- EPS TTM
- $2.49
- P/B TTM
- 2.52x
- ROE TTM
- 15.49%
- ROA TTM
- 8.45%
- Debt To Equity
- 0.26x
- Free Cash Flow TTM
- $3.63B
- Net Revenue TTM Growth 1Y
- 13.52%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BOSTON SCIENTIFIC CORP in?
BOSTON SCIENTIFIC CORP (BSX) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does BSX trade on?
BOSTON SCIENTIFIC CORP (BSX) trades on the NYSE.
Where is BOSTON SCIENTIFIC CORP incorporated?
BOSTON SCIENTIFIC CORP is incorporated in DE.
When was BOSTON SCIENTIFIC CORP (BSX)'s most recent SEC filing?
BOSTON SCIENTIFIC CORP (BSX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-03.
What is BSX's market cap?
BOSTON SCIENTIFIC CORP (BSX) has a market capitalization of $62.75B as of 2026-06-30.
What is BSX's P/E ratio?
BOSTON SCIENTIFIC CORP (BSX)'s trailing twelve month P/E ratio is 17.11x as of 2026-06-30.
What is BSX's EPS (earnings per share)?
BOSTON SCIENTIFIC CORP (BSX)'s trailing twelve month EPS is $2.49 as of 2026-06-30.
What is BSX's ROE (return on equity)?
BOSTON SCIENTIFIC CORP (BSX)'s trailing twelve month Return on Equity (ROE) is 15.49% as of 2026-06-30.
What is BSX's ROA (return on assets)?
BOSTON SCIENTIFIC CORP (BSX)'s trailing twelve month Return on Assets (ROA) is 8.45% as of 2026-06-30.
What is BSX's ROIC (return on invested capital)?
BOSTON SCIENTIFIC CORP (BSX)'s trailing twelve month Return on Invested Capital (ROIC) is 11.10% as of 2026-06-30.
What is BSX's EV/EBITDA?
BOSTON SCIENTIFIC CORP (BSX)'s trailing twelve month EV/EBITDA is 13.41x as of 2026-06-30.